Speakers:

• Len van Zyl, Ph.D., CEO, ArrayXpress Inc., Raleigh, NC
• Kirk Hartley, Principal, LSP Group LLC, Chicago, IL 
• Michael Zapata, Executive Chairman, ArrayXpress Inc., Cary, North Carolina

Topics for discussion include:

• • Multiple court orders and stipulations for broad genetic testing
  • Researchers prove thousands of VUSs are in fact pathogenic
  • Estimate that mutations alone cause 20% of mesotheliomas
  • BARD1 joins BAP1 as a single mutation cause of mesothelioma
  • Some combinations of "benign" mutations can be pathogenic
  • More focus on BRCA1 and 2 mutations in mesotheliomas
  • New examples of why Whole Genome Sequencing should be used
  • Value of obtaining sequencing data from commercial labs